
Friday, June 20, 2025 11:09:16 AM
I do believe the algae issue has been resolved and I don't remember 80 foot depths ever being an issue. Very strong currents that have come in close to the shore are a problem but they have a solution for that as well.
And the discounts are just how these small companies generally raise funds so I don't hold anything against them for investing. Just the nature of the beast.
I think a real problem would be a problem that crops up and they don't have a solution for it. Seafarer has worked through every single problem they've encountered thus far. And there have been a lot over the years. Got to give them credit for that regardless of the constant delays.
An now Kyle is the 17B share man? Ooof, that's a lot of shares. Yet, there seem to be at least a few out there who like it as the price is headed up this morning. Maybe a new investor has laid eyes on the lab and likes what they see? Financing deal come through? Whatever has happened, I like it.
Also agree that Juno has got to produce. Got to in my opinion.

Recent SFRX News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2025 02:08:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 08:36:27 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/22/2025 09:03:21 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/09/2025 08:52:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 10:07:18 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:54:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 05:30:15 PM
VAYK Project 100% Revenue Growth Before Half Year Report • VAYK • Jul 14, 2025 8:58 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM